CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Cachexia has been recognized as a direct cause of reduced quality of life complicating in cancer patients. Patients with pancreatic ...
Taipei, Taiwan
in first line treatment naïve subjects with Stage IV metastatic pancreatic carcinoma. The first part of study will focus on the treatment of ...
Phase 1, Phase 2
Taipei, Taiwan and 8 other locations
The purpose of this study is to confirm the recommended phase 2 dose (RP2D) of zolbetuximab in combination with Nab-P + GEM, determine overall surviv...
Phase 2
Taipei City, Taiwan and 137 other locations
of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...
Phase 2
Taipei City, Taiwan and 46 other locations
This is a Phase I/II, open-label, multi-center, multi-national, dose escalation, single agent study to assess the safety, tolerability, PK, PD, immun...
Phase 2
Taipei, Taiwan and 64 other locations
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor...
Phase 1
Taipei, Taiwan and 63 other locations
This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...
Phase 2
Taipei City, Taiwan and 122 other locations
A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid Tumors
Phase 1
Taipei, Taiwan and 15 other locations
ACE1702 (anti-HER2 oNK cells) is an off-the-shelf Natural Killer (NK) cell product that targets human HER2-expressing solid tumors. The ACE1702-001 p...
Phase 1
Taipei, Taiwan and 2 other locations
(E7080/MK-7902) in participants with triple negative breast cancer (TNBC), ovarian cancer, gastric cancer, colorectal cancer...
Phase 2
Taipei, Taiwan and 87 other locations
Clinical trials
Research sites
Resources
Legal